These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 30946771
1. Prediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals. Yang HY. PLoS One; 2019; 14(4):e0214808. PubMed ID: 30946771 [Abstract] [Full Text] [Related]
2. Significance of serum mesothelin in an asbestos-exposed population in the Czech Republic. Jakubec P, Pelclova D, Smolkova P, Kolek V, Nakladalova M. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):472-9. PubMed ID: 24781044 [Abstract] [Full Text] [Related]
3. Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure. Demir M, Kaya H, Taylan M, Ekinci A, Yılmaz S, Teke F, Sezgi C, Tanrikulu AC, Meteroglu F, Senyigit A. Lung; 2016 Jun; 194(3):409-17. PubMed ID: 27032653 [Abstract] [Full Text] [Related]
4. Decline in annual lung function in workers exposed to asbestos with and without pre-existing fibrotic changes on chest radiography. Nakadate T. Occup Environ Med; 1995 Jun; 52(6):368-73. PubMed ID: 7627312 [Abstract] [Full Text] [Related]
5. Pulmonary fibrosis in workers exposed to non-asbestiform tremolite asbestos minerals. Yang HY, Shie RH, Chen PC. Epidemiology; 2013 Jan; 24(1):143-9. PubMed ID: 22983200 [Abstract] [Full Text] [Related]
6. Mesothelin (MSLN) methylation and soluble mesothelin-related protein levels in a Chinese asbestos-exposed population. Yu M, Zhang Y, Jiang Z, Chen J, Liu L, Lou J, Zhang X. Environ Health Prev Med; 2015 Sep; 20(5):369-78. PubMed ID: 26188910 [Abstract] [Full Text] [Related]
7. Individual predictors of increased serum mesothelin in asbestos-exposed workers. Filiberti R, Marroni P, Mencoboni M, Mortara V, Caruso P, Cioè A, Michelazzi L, Merlo DF, Bruzzone A, Bobbio B, Del Corso L, Galli R, Taveggia P, Dini G, Spigno F. Med Oncol; 2013 Mar; 30(1):422. PubMed ID: 23277285 [Abstract] [Full Text] [Related]
8. High prevalence of reversible airway obstruction in asbestos-exposed workers. Delpierre S, Delvolgo-Gori MJ, Faucher M, Jammes Y. Arch Environ Health; 2002 Mar; 57(5):441-5. PubMed ID: 12641187 [Abstract] [Full Text] [Related]
9. Sensitivity of urinary mesothelin in patients with malignant mesothelioma. Creaney J, Musk AW, Robinson BW. J Thorac Oncol; 2010 Sep; 5(9):1461-6. PubMed ID: 20815094 [Abstract] [Full Text] [Related]
10. Pulmonary function of nonsmoking female asbestos workers without radiographic signs of asbestosis. Wang XR, Yano E, Nonaka K, Wang M, Wang Z. Arch Environ Health; 1998 Sep; 53(4):292-8. PubMed ID: 9709994 [Abstract] [Full Text] [Related]
11. Respiratory effects from industrial talc exposure among former mining workers. Loyola RC, Carneiro AP, Silveira AM, La Rocca Pde F, Nascimento MS, Chaves RH. Rev Saude Publica; 2010 Jun; 44(3):541-7. PubMed ID: 20499013 [Abstract] [Full Text] [Related]
12. Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population. Jiang Z, Ying S, Shen W, He X, Chen J, Xia H, Yu M, Xiao Y, Feng L, Zhu L, Ju L, Guo X, Zhang Y, Shen JW, Tong Y, Zhang X, Lou J. Dis Markers; 2017 Jun; 2017():1725354. PubMed ID: 29200597 [Abstract] [Full Text] [Related]
13. Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases. Goricar K, Kovac V, Dodic-Fikfak M, Dolzan V, Franko A. Radiol Oncol; 2020 Mar 07; 54(1):86-95. PubMed ID: 32187018 [Abstract] [Full Text] [Related]
14. [Analysis of changes in radiographic lung image and lung ventilation disorders in workers occupationally exposed to chrysotile in the past]. Cwynar E, Świątkowska B, Tomczyk J. Med Pr; 2017 Mar 24; 68(2):247-258. PubMed ID: 28345684 [Abstract] [Full Text] [Related]
15. Asbestos exposure biomarkers in the follow-up of asbestos-exposed workers. Paolucci V, Romeo R, Sisinni AG, Scancarello G, Volterrani L, Mazzei MA, Barabesi L, Sartorelli P. Ind Health; 2018 Jun 01; 56(3):249-254. PubMed ID: 29479016 [Abstract] [Full Text] [Related]
16. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study. Xue C, Wu N, Li X, Qiu M, Du X, Ye Q. BMC Pulm Med; 2017 Nov 17; 17(1):144. PubMed ID: 29149883 [Abstract] [Full Text] [Related]
17. Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure. Rodríguez Portal JA, Rodríguez Becerra E, Rodríguez Rodríguez D, Alfageme Michavila I, Quero Martínez A, Diego Roza C, León Jiménez A, Isidro Montes I, Cebollero Rivas P. Cancer Epidemiol Biomarkers Prev; 2009 Feb 17; 18(2):646-50. PubMed ID: 19190155 [Abstract] [Full Text] [Related]
18. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. Pass HI, Wali A, Tang N, Ivanova A, Ivanov S, Harbut M, Carbone M, Allard J. Ann Thorac Surg; 2008 Jan 17; 85(1):265-72; discussion 272. PubMed ID: 18154821 [Abstract] [Full Text] [Related]
19. Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study. Park EK, Sandrini A, Yates DH, Creaney J, Robinson BW, Thomas PS, Johnson AR. Am J Respir Crit Care Med; 2008 Oct 15; 178(8):832-7. PubMed ID: 18583574 [Abstract] [Full Text] [Related]
20. Respiratory impairments due to dust exposure: a comparative study among workers exposed to silica, asbestos, and coalmine dust. Wang X, Yano E, Nonaka K, Wang M, Wang Z. Am J Ind Med; 1997 May 15; 31(5):495-502. PubMed ID: 9099350 [Abstract] [Full Text] [Related] Page: [Next] [New Search]